Young S, Raboud J, Dodd Z, DeBeck K, Milloy MJ, Wilson D, Hayashi K, Bayoumi AM, Fairbairn N Examining the association between fentanyl use and perceived adequacy of methadone dose: a retrospective cohort study Drug Alcohol Depend PubMed

Young S, Fairbairn N, Cui Z, Bach P, Mok WY, Budau J, Slaunwhite A, Ti L, Hayashi K, Nolan S Association between prescribed stimulant medications and overdose among individuals receiving opioid agonist therapy: a retrospective cohort study from British Columbia, Canada Addiction PubMed

Nolan S, Kelian S, Kerr T, Young S, Malmgren I, Ghafari C, Harrison S, Wood E, Lysyshyn M, Holliday E Harm reduction in the hospital: an overdose prevention site (OPS) at a Canadian hospital Drug Alcohol Depend PubMed

Shearer D, Young S, Fairbairn N, Brar R Challenges with buprenorphine inductions in the context of the fentanyl overdose crisis: a case series Drug Alcohol Rev PubMed

Young S, Hayashi K, Grant C, Milloy MJ, DeBeck K, Wood E, Fairbairn N Buprenorphine/naloxone associated with a reduced odds of fentanyl exposure among a cohort of people who use drugs in Vancouver, Canada Drug Alcohol Depend PubMed

McAdam M, Brar R, Young S Initiation of injectable opioid agonist treatment in hospital: a case report Drug Alcohol Rev PubMed